Nicholas Hoffman & Company, Llc. Eli Lilly & CO Transaction History

Nicholas Hoffman & Company, Llc.

$2.35 Billion
Q3 2024

A detailed history of Nicholas Hoffman & Company, Llc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Nicholas Hoffman & Company, Llc. holds 10,219 shares of LLY stock, worth $8.13 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

10,219

Previous 11,880 13.98%

Holding current value

$8.13 Million

Previous $10.8 Million 15.83%

% of portfolio

0.39%

Previous 0.51%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$772.14 - $960.02 $1.28 Million - $1.59 Million	-1,661 Reduced 13.98%	10,219 $9.05 Million
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $106,555 - $133,628	-147 Reduced 1.22%	11,880 $10.8 Million
Q1 2024 Apr 22, 2024	SELL	$592.2 - $792.28 $139,167 - $186,185	-235 Reduced 1.92%	12,027 $9.36 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $45,166 - $53,245	-86 Reduced 0.7%	12,262 $7.15 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $1.46 Million - $2.01 Million	-3,358 Reduced 21.38%	12,348 $6.63 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $213,249 - $285,139	608 Added 4.03%	15,706 $7.37 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $20,812 - $24,442	67 Added 0.45%	15,098 $5.18 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $10,932 - $12,738	34 Added 0.23%	15,031 $5.5 Million
Q3 2022 Nov 04, 2022	SELL	$296.48 - $337.87 $120,074 - $136,837	-405 Reduced 2.63%	14,997 $4.85 Million
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $525,684 - $617,231	1,886 Added 13.95%	15,402 $4.99 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $128,140 - $159,246	-546 Reduced 3.88%	13,516 $3.87 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $5,396 - $6,696	24 Added 0.17%	14,062 $3.88 Million
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $159,773 - $196,623	-721 Reduced 4.89%	14,038 $3.24 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $90,997 - $117,704	504 Added 3.54%	14,759 $3.39 Million
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $48,145 - $62,326	293 Added 2.1%	14,255 $2.66 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $11,871 - $15,709	91 Added 0.66%	13,962 $2.36 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $43,866 - $50,739	300 Added 2.21%	13,871 $2.05 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $5,866 - $7,059	43 Added 0.32%	13,571 $2.23 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $1,071 - $1,326	-9 Reduced 0.07%	13,528 $1.88 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $53,566 - $66,347	-501 Reduced 3.57%	13,537 $1.78 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $32,357 - $35,196	-303 Reduced 2.11%	14,038 $1.57 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $142,143 - $165,917	-1,283 Reduced 8.21%	14,341 $1.59 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $228,519 - $268,984	2,053 Added 15.13%	15,624 $2.03 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $26,898 - $30,134	-254 Reduced 1.84%	13,571 $1.57 Million
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $171,805 - $214,727	2,001 Added 16.92%	13,825 $1.48 Million
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $62,679 - $71,936	-828 Reduced 6.54%	11,824 $1.01 Million
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $1,706 - $2,014	-23 Reduced 0.18%	12,652 $979,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $77 - $85	1 Added 0.01%	12,675 $1.08 Million
Q2 2017 Aug 14, 2017	BUY	N/A	12,674	12,674 $1.04 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Hoffman & Company, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Hoffman & Company, Llc. with notifications on news.

Account

Nicholas Hoffman & Company, Llc. Eli Lilly & CO Transaction History